Opinion

  • Modern care, old systems: Why healthcare remains a prime cyber target

    By Colette Kitterhing, vice president of UK and Ireland at Netskope Healthcare is changing at a rapid pace, as the health industry digitally transforms to meet patient expectations. Despite this, trust is still delicate in the industry. When people can't book appointments, deal with broken communication between clinicians or receive incorrect diagnoses, their confidence deteriorates. [...]

  • Why DSPT compliance is vital to securing healthcare’s mobile frontline

    By Adam Boynton, senior security strategy manager at Jamf Mobile devices have become the NHS’s most quietly transformative tools. Whether on a ward round, at a community visit, or during an emergency response, clinicians now rely on phones and tablets as instinctively as they once reached for a penlight.   These endpoints carry [...]

  • Prostate cancer screening for all UK men not justified – experts

    A national prostate cancer screening programme is not justified for all UK men, the UK National Screening Committee has advised. The committee said mass screening would be "likely to cause more harm than good" and backed testing only for men with BRCA genetic variants. BRCA variants are inherited DNA changes that can raise cancer risk. [...]

  • “We need to move from crisis response to early action” – health tech leaders react to UK Budget

    The UK’s 2025 Autumn Budget has outlined a series of measures with direct implications for the health tech sector, signalling a renewed push to modernise NHS infrastructure and expand tech-enabled care. At the centre of the announcement is £300m in new capital funding for NHS technology, positioned as critical to upgrading digital systems, strengthening data infrastructure [...]

  • Expert comment: Why wearables won’t win on features alone

    By James Greenfield, CEO, Koto In the late 2000s, we all started seeing wearable technology for the first time. From the trendy Nike FuelBand to the more Dad-adjacent Fitbit, we began counting our steps. Fast forward a few years and suddenly people were talking about sleep scores. Fast forward again and its strain, irregular rhythms [...]

  • Ergéa Group appoints David Rolfe as new Group Chief Executive Officer

    Ergéa, a leading pan-European healthcare company specialising in diagnostic imaging and cancer care, has appointed David Rolfe as Group CEO and named Mark Graves as CEO of Ergéa UK. Effective 24 November 2025, David Rolfe, the outgoing CEO of Ergéa UK, has been appointed CEO of Ergéa Group. As part of this leadership transition, Mark [...]

  • Rebuilding trust in the NHS: AI as the catalyst for human-first care

    By Alfred Olivares, Global Managing Partner, Healthcare & MedTech at HTEC The NHS, once the envy of the world, is now facing the expectations of a generation raised on instant access and personalised services. Research from the Independent Healthcare Provider Network shows that half of millennials plan to use private healthcare in the next year, [...]

  • Mapping growth and innovation in men’s health

    As men’s health moves from a relatively niche category to a well-capitalised, innovation-driven market, it's a sector gaining momentum. According to data from FounderNest, an AI-powered market intelligence platform, digital diagnostics, mental health platforms, fertility solutions, and preventative care technologies are attracting significant investment and scaling rapidly. These innovations are collectively shaping the next generation [...]

  • Opportunities on the horizon: What’s next for European life sciences investment

    By McDermott Will & Schulte European life sciences businesses have been closely tracking geopolitics and global policy changes over the past 12 months, particularly as the new administration in the United States heightens its focus on drug pricing. Against this backdrop, hundreds of healthcare professionals, investors, and industry changemakers gathered in London for McDermott Will [...]

  • Stock markets rise as Nvidia CEO quells AI ‘bubble’ fears

    Global markets rose after Nvidia posted third-quarter earnings that exceeded Wall Street estimates, easing concerns about AI sector valuations. The chipmaker reported US$1.30 in diluted earnings per share on US$57.01bn in total revenues, beating investor expectations of US$1.26 on US$54.9bn. Sales increased 62 per cent year on year. Nvidia, the world's most valuable [...]